Bob Kiss is Vice President of Process and Analytical Development at Sutro Biopharma, a company developing novel human biotherapeutics. He has more than 27 years of industrial biotechnology experience. Prior to Sutro, Bob spent 24 years at Genentech, where his final role was Senior Director and Distinguished Engineer leading cell culture development. His career focus areas have included control of product quality, barriers to adventitious agent contamination, and process scaleup and transfer for cell culture and fermentation processes. He currently focuses on industrializing the Sutro cell-free protein synthesis platform. He has participated in numerous industry/academia consortia within the biotechnology community, and was a director of AIChE’s Food, Pharmaceutical and Bioengineering Div. Bob received a BS (Univ. of California, Davis), MS (MIT), and PhD (MIT), all in chemical engineering. He is a licensed Professional Engineer and an elected member of the National Academy of Engineering.